Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001357177-11-000010)

Filing Details

Accession Number:: 0001357177-11-000010
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-09-27 12:15:14
Reporting Period:: 2011-04-13

Filing Date:: 2011-09-27
Accepted Time:: 2011-09-27 12:15:14
Original Submission Date:: 2011-04-13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159019	Stellar Pharmaceuticals Inc	SLXCF	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1357177	Roy Peter Riehl	14 Exmoor Place London A6 N5X 3W2		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2011-04-05	20,000	$0.51	3,454,741	No	4	S	Direct
Common Shares	Disposition	2011-04-05	20,000	$0.50	3,434,741	No	4	S	Direct
Common Shares	Disposition	2011-04-12	2,500	$0.69	3,432,241	No	4	S	Direct
Common Shares	Disposition	2011-04-12	47,500	$0.68	3,384,741	No	4	S	Direct
Common Shares	Disposition	2011-04-21	13,735	$0.72	3,371,006	No	4	S	Direct
Common Shares	Disposition	2011-07-20	12,620	$0.62	3,358,386	No	4	S	Direct
Common Shares	Disposition	2011-07-25	17,380	$0.62	3,341,006	No	4	S	Direct
Common Shares	Disposition	2011-07-26	3,000	$0.62	3,338,006	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct